Walgreens is considering selling VillageMD, its $5.2 billion acquisition, due to challenges in generating profit amid economic pressures and changing pharmaceutical demands post-pandemic. Despite earlier efforts to cut costs by closing clinics, the company faces continued financial strain. Walgreens is exploring various options, including a potential sale or restructuring. This reflects a broader trend of difficulties faced by major companies like Walmart and CVS in the healthcare delivery sector, highlighting the complex economics and challenges of primary care ventures.
Walgreens’ Potential Sale Of VillageMD Yet Again Signals The Challenges Of Care Delivery (Forbes)
0